JPRN-UMIN000004370已完成未知
Clinical research to evaluate the contribution of drug transporters and drug metabolizing enzymes for PI boosting by ritonavir - PI boosting microdose study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- APDD
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •the investigors must ensure that all subjects being considerd meet the following exclusion criteria or conditions: 1)history of allergy to any drugs 2)medical attention within 2 months prior to participation 3)donation of 200mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4)donation of 400mL or more of blood within 12 weeks prior to participation 5)recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6)history of drug abuse 7)alcohol abuse
研究者
相似试验
招募中
不适用
The clinical research to evaluate the efficacy of landiolol on cardiac function in patients with acute heart failureacute heart failureJPRN-UMIN000004342Department of Medicine and Clinical Science Yamaguchi University25
尚未招募
不适用
Clinical research study to evaluate the effect on gingival inflammation of a toothpaste containing vitamin D in patients with established dental plaque and gingivitis.GingivitisACTRN12621000885897The University of Queensland80
已完成
不适用
A clinical research to evaluate the performance of Straumann Tissue Level Implants with SLA surface in Single Tooth Gaps in the pre-molar and molar regioSingle Tooth Gaps in the pre-molar and molar regionJPRN-UMIN000007740Tokyo Medical and Dental University40
尚未招募
3 期
Management of Generalised Anxiety Disorder with Shirodhara and Sarvanga AbhyangaCTRI/2022/09/045565Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
进行中（未招募）
不适用
Klinische Studie zur Untersuchung der Wirkung von Weißdorn-Extrakt WS® 1442 auf die Lebensqualität von Patienten mit Herzinsuffizienz NYHA II, die ein moderates Ausdauertraining absolvierenEine monozentrische, offene klinische Prüfung der Phase IV im ParallelgruppendesignEUCTR2006-004523-11-DEDr. Willmar Schwabe GmbH & Co. KG